AstraZeneca Targets Torrent Again Over Seroquel ANDA

Law360, New York (October 1, 2010, 5:42 PM EDT) -- AstraZeneca Pharmaceuticals LP has again sued Torrent Pharmaceuticals Ltd. over efforts to produce a copycat version of schizophrenia treatment Seroquel XR, claiming that the generics maker's abbreviated new drug application for a lower strength of the drug also infringes a patent.

AstraZeneca lodged filed suit Tuesday in the U.S. District Court for the District of New Jersey, seeking to block India-based Torrent and its U.S. subsidiary Torrent Inc. from manufacturing a 50 mg strength version of generic Seroquel XR before U.S. Patent Number 5,948,437 expires in...
To view the full article, register now.